https://www.technologytimesnewjersey.com/article/910242598-candel-therapeutics-to-host-investor-conference-call-following-presentation-of-extended-data-from-phase-3-trial-of-aglatimagene-besadenovec-in Technology Times New Jersey en PressRelease 2026-05-04T12:05:00+00:00 Candel Therapeutics to Host Investor Conference Call Following Presentation of Extended Data from Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png https://www.technologytimesnewjersey.com/article/910242367-proqr-announces-annual-general-meeting-of-shareholders-to-be-held-june-2-2026 Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026 https://ml-eu.globenewswire.com/media/f5ae7794-bff7-44dc-8709-0e9c3a9eac77/small/logo-proqr-150x150-png.png https://www.technologytimesnewjersey.com/article/910242370-dr-falk-pharma-and-renexxion-announce-positive-results-on-naronapride-in-gastroparesis-from-the-global-phase-2b-move-it-trial Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial https://ml-eu.globenewswire.com/media/7cf77d4a-25b5-4471-a282-0334907cbfbd/small/falk-logo-rgb-jpg.jpg https://www.technologytimesnewjersey.com/article/910242372-dr-falk-pharma-and-renexxion-announce-positive-results-on-naronapride-in-gastroparesis-from-the-global-phase-2b-move-it-trial Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial https://ml-eu.globenewswire.com/media/540f0a78-db35-42ad-9e90-7b81e8ff3ad6/small/renirl-logo-png.png https://www.technologytimesnewjersey.com/article/910242373-cptx-to-present-preclinical-proof-of-principle-of-its-dna-based-in-vivo-car-t-platform-at-asgct-annual-meeting Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 CPTx to present preclinical proof-of-principle of its DNA-based in vivo CAR T platform at ASGCT Annual Meeting https://ml-eu.globenewswire.com/media/b3ec9ca7-8866-466a-9d91-09342002e341/small/cptx-logo-high-res-png.png https://www.technologytimesnewjersey.com/article/910242419-evaxion-to-announce-business-update-and-first-quarter-2026-financial-results-on-may-7-2026 Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026 https://ml-eu.globenewswire.com/media/19d0d69c-7f37-4d3b-8f26-2866d4ec3311/small/evaxion-deepblue-rgb-png.png https://www.technologytimesnewjersey.com/article/910242435-recludix-pharma-announces-upcoming-oral-presentations-on-preclinical-data-for-oral-stat6-inhibitor-rex-8756-and-topical-stat-1-3-inhibitors-at-the Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Recludix Pharma Announces Upcoming Oral Presentations on Preclinical Data for Oral STAT6 Inhibitor REX-8756 and Topical STAT 1/3 Inhibitors at the Society for Investigative Dermatology (SID) Annual Meeting https://ml.globenewswire.com/media/NDM5ZGUzYTItNGI0Zi00N2Y3LWE3Y2QtZmViNDYyN2I1ZWRjLTEyMzYyMjItMjAyNi0wNS0wNC1lbg==/tiny/Recludix-Pharma-Inc-.png https://www.technologytimesnewjersey.com/article/910242438-rhythm-pharmaceuticals-announces-new-data-presentations-in-acquired-hypothalamic-obesity-at-pediatric-endocrine-society Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg https://www.technologytimesnewjersey.com/article/910242442-spur-therapeutics-presents-clinical-insights-on-bone-disease-impact-of-flt201-in-adults-with-gaucher-disease-type-1 Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Spur Therapeutics Presents Clinical Insights on Bone Disease Impact of FLT201 in Adults with Gaucher Disease Type 1 https://ml.globenewswire.com/media/195ccecc-f977-4fb5-ba01-43af7ec47589/small/spur-therapeutics-black-wopacity-rgb-png.png https://www.technologytimesnewjersey.com/article/910242445-zoom-recognizes-the-rise-of-ai-powered-businesses-of-one-with-inaugural-solopreneur-50 Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Zoom Recognizes the Rise of AI-Powered Businesses of One with Inaugural Solopreneur 50 https://ml.globenewswire.com/media/1a5e6f52-9a8e-432b-84cc-7dfb0e6623e2/small/logo-zm-app-icon-container-png.png https://www.technologytimesnewjersey.com/article/910242449-kyverna-therapeutics-appoints-nadia-dac-seasoned-commercial-leader-in-neurology-and-rare-disease-as-chief-commercial-officer Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer https://ml.globenewswire.com/media/c166e9f5-941a-48b0-be17-c24d54785784/small/kyverna-primary-full-2-png.png https://www.technologytimesnewjersey.com/article/910242457-4dmt-to-participate-in-upcoming-investor-conferences Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 4DMT to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png https://www.technologytimesnewjersey.com/article/910242470-valitor-presents-preclinical-data-demonstrating-superior-durability-with-six-month-treatment-protocol-of-vltr-559-to-treat-wet-amd Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Valitor Presents Preclinical Data Demonstrating Superior Durability with Six-month Treatment Protocol of VLTR-559 to Treat Wet AMD https://ml.globenewswire.com/media/58da3c80-c616-4358-9bbe-2936ace96649/small/valitor-sidebyside-png.png https://www.technologytimesnewjersey.com/article/910242472-applied-digital-announces-300-million-senior-secured-bridge-facility Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Applied Digital Announces $300 Million Senior Secured Bridge Facility https://ml.globenewswire.com/media/a09f7f80-1e66-44ed-b53a-6007ec7be92a/small/applied-digital-logo-horizontal-black-png.png https://www.technologytimesnewjersey.com/article/910242494-tessell-appoints-matt-mcdonough-and-jeffrey-carter-to-executive-team-to-accelerate-enterprise-database-modernization Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Tessell Appoints Matt McDonough and Jeffrey Carter to Executive Team to Accelerate Enterprise Database Modernization https://ml.globenewswire.com/media/503f121a-0162-4ce3-84b3-ae5e04dc98e5/medium/jeff-carter-chief-strategy-officer.jpeg https://www.technologytimesnewjersey.com/article/910242516-kaltura-open-sources-suite-of-ai-agent-skills-enabling-any-ai-agent-to-build-intelligent-rich-media-digital-experiences Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Kaltura Open-Sources Suite of AI Agent Skills, Enabling Any AI Agent to Build Intelligent Rich-Media Digital Experiences https://ml.globenewswire.com/media/584e487b-dd12-4a20-a5b1-c42f4579d369/small/kaltura-logo-vertical-colorsun-blacktext-small.png https://www.technologytimesnewjersey.com/article/910242538-lifeward-announces-new-rewalk-data-presented-at-asia-2026-conference-demonstrating-a-comprehensive-longitudinal-safety-analysis-for-a-powered Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered Exoskeleton https://ml.globenewswire.com/media/9343d7ac-5bc7-4a60-a2c9-a41bf7b5e007/small/lifeward-full-logo-rgb-for-web-01-jpg.jpg https://www.technologytimesnewjersey.com/article/910242564-atsena-presents-positive-interim-six-month-results-from-part-b-of-phase-1-2-3-lighthouse-trial-evaluating-atsn-201-in-patients-with-x-linked Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Atsena Presents Positive Interim Six-Month Results from Part B of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis https://ml.globenewswire.com/media/90d0bd84-4404-435c-9875-3473b4cc7172/small/atsena-logo-jpg.jpg https://www.technologytimesnewjersey.com/article/910242567-rocket-doctor-ai-reports-strong-2025-results-validating-physician-led-model-with-key-u-s-payer-contracts-and-ai-innovation Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Rocket Doctor AI Reports Strong 2025 Results, Validating Physician-Led Model with Key U.S. Payer Contracts and AI Innovation https://ml.globenewswire.com/media/648c6dd6-c4c0-4ceb-9a78-26fecd4678a7/small/rocket-doctor-logo-250821-png.png https://www.technologytimesnewjersey.com/article/910242574-after-successful-fda-meeting-clene-filing-accelerated-approval-nda-for-als Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS https://ml.globenewswire.com/media/e9de96a4-582e-4975-8e43-6f3e6259c075/small/clene-logo-2x-png.png https://www.technologytimesnewjersey.com/article/910242582-legend-biotech-expands-scientific-advisory-expertise-to-inform-future-growth Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth https://ml.globenewswire.com/media/d3a680c2-cab6-4eb2-9ed0-7be055f9e180/small/legend-logo-fullcolor-transparent-1-png.png https://www.technologytimesnewjersey.com/article/910242595-swarmer-partners-with-rakuten-to-enter-japan-s-advanced-autonomy-market Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Swarmer Partners With Rakuten to Enter Japan's Advanced Autonomy Market https://ml.globenewswire.com/media/46b28796-9654-4d2b-89db-91de399ba76a/small/swarmer-logo-dark-png.png https://www.technologytimesnewjersey.com/article/910242608-ruanyun-edai-technology-s-saudi-rhq-signs-mou-with-wadi-makkah-a-subsidiary-of-umm-al-qura-university Technology Times New Jersey en PressRelease 2026-05-04T12:00:00+00:00 Ruanyun Edai Technology’s Saudi RHQ Signs MOU with Wadi Makkah, A Subsidiary of Umm Al-Qura University https://ml.globenewswire.com/media/0b7372f3-6354-4bba-acc5-bb10b1de4c3a/small/logo-jpg.jpg https://www.technologytimesnewjersey.com/article/910237832-macrogenics-and-sagard-healthcare-partners-enter-into-expanded-zynyz-royalty-purchase-agreement Technology Times New Jersey en PressRelease 2026-05-04T11:30:00+00:00 MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement https://ml.globenewswire.com/media/72a7b58c-b7ca-4cd5-b2bb-185124351f1c/small/macrogenics-logo-transparent-background-png.png https://www.technologytimesnewjersey.com/article/910237841-bridgebio-to-present-new-acoramidis-data-on-disease-progression-biomarkers-and-clinical-outcomes-at-esc-heart-failure-2026 Technology Times New Jersey en PressRelease 2026-05-04T11:30:00+00:00 BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026 https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://www.technologytimesnewjersey.com/article/910237849-kura-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Technology Times New Jersey en PressRelease 2026-05-04T11:30:00+00:00 Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/ebf510d7-3727-4cc8-894f-6ce2d82b941a/small/kura-logo-for-globe-newswire-prs-png.png https://www.technologytimesnewjersey.com/article/910237860-palvella-therapeutics-announces-first-patients-dosed-in-phase-2-lotu-trial-of-fast-track-designated-qtorin-rapamycin-for-clinically-significant Technology Times New Jersey en PressRelease 2026-05-04T11:30:00+00:00 Palvella Therapeutics Announces First Patients Dosed in Phase 2 LOTU Trial of Fast Track-Designated QTORIN™ Rapamycin for Clinically Significant Angiokeratomas https://ml.globenewswire.com/media/83fd569b-5e6c-46ad-882a-6430f8ab755a/small/palvella-2025-logo-new-jpg.jpg https://www.technologytimesnewjersey.com/article/910237878-inflarx-reports-favorable-reactive-metabolite-profile-for-izicopan-in-human-liver-microsomes Technology Times New Jersey en PressRelease 2026-05-04T11:30:00+00:00 InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes https://ml.globenewswire.com/media/e017df5c-9a9b-4f4f-9a94-6c2eeb0400bc/small/inflarx-logo-png.png https://www.technologytimesnewjersey.com/article/910237897-earthdaily-advancing-daily-global-measurement-of-planetary-change-with-six-satellites-launched Technology Times New Jersey en PressRelease 2026-05-04T11:30:00+00:00 EarthDaily Advancing Daily Global Measurement of Planetary Change with Six Satellites Launched https://ml.globenewswire.com/media/63895f31-922c-451d-894e-110f2f640ad9/medium/earthdaily-satellite-deploys.png https://www.technologytimesnewjersey.com/article/910237911-windward-bio-announces-165m-crossover-financing-to-advance-pipeline-of-long-acting-immunology-therapies-with-best-in-disease-potential Technology Times New Jersey en PressRelease 2026-05-04T11:30:00+00:00 Windward Bio Announces $165M Crossover Financing to Advance Pipeline of Long-Acting Immunology Therapies With Best-in-Disease Potential https://ml.globenewswire.com/media/Nzk5NDkzNGQtNWZiNi00MGZkLTg2ZTAtYzViNDkwNTJjOTVmLTUwMDEzMTYxMS0yMDI2LTA1LTA0LWVu/tiny/Windward-Bio.png https://www.technologytimesnewjersey.com/article/910237925-micropolis-robotics-unveils-new-next-generation-high-endurance-robot-at-the-make-it-in-the-emirates-2026-industry-exhibition Technology Times New Jersey en PressRelease 2026-05-04T11:29:19+00:00 Micropolis Robotics Unveils New, Next-Generation, High-Endurance Robot at the Make it in the Emirates 2026 Industry Exhibition https://ml.globenewswire.com/media/ffdb8f0a-5da0-4cdc-9a97-852140e69d8b/medium/m1-5.JPG https://www.technologytimesnewjersey.com/article/910237843-cartesian-therapeutics-announces-new-employment-inducement-grants Technology Times New Jersey en PressRelease 2026-05-04T11:05:00+00:00 Cartesian Therapeutics Announces New Employment Inducement Grants https://ml.globenewswire.com/media/2bf78841-be30-4bb5-bfb5-0b5f383f3302/small/cartesian-logo-color-png.png https://www.technologytimesnewjersey.com/article/910237845-nextcure-and-simcere-zaiming-initiate-dose-optimization-for-sim0505-cdh6-adc-in-gynecologic-cancers Technology Times New Jersey en PressRelease 2026-05-04T11:05:00+00:00 NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancers https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg https://www.technologytimesnewjersey.com/article/910237870-kraig-biocraft-laboratories-launches-april-may-production-cycle-following-record-spider-silk-output Technology Times New Jersey en PressRelease 2026-05-04T11:05:00+00:00 Kraig Biocraft Laboratories Launches April/May Production Cycle Following Record Spider Silk Output https://ml.globenewswire.com/media/3cf5ab91-0822-460b-bb13-17447941c84a/small/kblb-logo-jpg.jpg https://www.technologytimesnewjersey.com/article/910233519-ardena-strengthens-executive-team-to-drive-its-next-phase-of-growth Technology Times New Jersey en PressRelease 2026-05-04T11:00:00+00:00 Ardena Strengthens Executive Team to Drive its Next Phase of Growth https://ml-eu.globenewswire.com/media/eddef504-18ee-4f10-8442-9e61ef77e262/medium/ardena-appoints-cfo-and-cco.png https://www.technologytimesnewjersey.com/article/910233520-indivior-announces-175-million-accelerated-share-repurchase Technology Times New Jersey en PressRelease 2026-05-04T11:00:00+00:00 Indivior Announces $175 Million Accelerated Share Repurchase https://ml-eu.globenewswire.com/media/42de3285-90ea-4020-a3ad-25f71026b41a/small/indivior-logo-jpg.jpg https://www.technologytimesnewjersey.com/article/910233589-advanced-technology-recycling-atr-announces-that-they-are-now-offering-wholesale-electronics-to-the-general-public-through-their-online-auction-site Technology Times New Jersey en PressRelease 2026-05-04T11:00:00+00:00 Advanced Technology Recycling (ATR) Announces That They Are Now Offering Wholesale Electronics to the General Public Through Their Online Auction Site https://ml.globenewswire.com/media/437d4f24-24b9-4cd4-961b-ea5dd0ab80ce/small/atr-logo-with-registered-trademark-badge-jpg.jpg https://www.technologytimesnewjersey.com/article/910233590-biocryst-announces-european-licensing-agreement-with-irish-affiliate-of-neopharmed-gentili-for-navenibart-in-hereditary-angioedema Technology Times New Jersey en PressRelease 2026-05-04T11:00:00+00:00 BioCryst Announces European Licensing Agreement with Irish Affiliate of Neopharmed Gentili for Navenibart in Hereditary Angioedema https://ml.globenewswire.com/media/8b033909-1a3c-4811-b07b-fe03b12e00d2/small/biocryst-primarylogo-r-2c-rgb-jpg.jpg https://www.technologytimesnewjersey.com/article/910233621-tenax-therapeutics-appoints-timothy-healey-mba-as-chief-commercial-officer Technology Times New Jersey en PressRelease 2026-05-04T11:00:00+00:00 Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer https://ml.globenewswire.com/media/d8c1d3b1-51a5-4835-a9e8-6d5bce14917e/small/tenax-logo-rgb-color-jpg.jpg https://www.technologytimesnewjersey.com/article/910233629-krystal-biotech-announces-first-quarter-2026-financial-and-operating-results Technology Times New Jersey en PressRelease 2026-05-04T11:00:00+00:00 Krystal Biotech Announces First Quarter 2026 Financial and Operating Results https://ml.globenewswire.com/media/94ec1f39-c0eb-4e65-9d7e-250519ef03f4/small/krys-logo-nobackground-with-registered-symbol-png.png https://www.technologytimesnewjersey.com/article/910233642-10-barrel-brewing-launches-clean-slate-and-salty-sips-expanding-rtd-line-with-functional-n-a-and-low-sugar-cocktails Technology Times New Jersey en PressRelease 2026-05-04T11:00:00+00:00 10 Barrel Brewing Launches Clean Slate and Salty Sips, Expanding RTD Line with Functional N/A and Low-Sugar Cocktails https://ml.globenewswire.com/media/5e71b27b-1cc8-4780-8689-8d8d6ae86236/medium/clean-slate-and-salty-sips.png https://www.technologytimesnewjersey.com/article/910233645-seres-therapeutics-presents-preclinical-data-at-digestive-disease-week-ddw-2026-supporting-ser-603-a-next-generation-cultivated-live-biotherapeutic Technology Times New Jersey en PressRelease 2026-05-04T11:00:00+00:00 Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease https://ml.globenewswire.com/media/f8c3ad50-d1a3-457d-b0c7-8f9237db7f93/small/seres-logo-png.png https://www.technologytimesnewjersey.com/article/910233649-centrum-launches-newly-reformulated-adults-50-complete-multivitamin-with-clinically-shown-cognitive-benefits Technology Times New Jersey en PressRelease 2026-05-04T11:00:00+00:00 Centrum Launches Newly Reformulated Adults 50+ Complete Multivitamin with Clinically Shown Cognitive Benefits https://ml.globenewswire.com/media/395df94a-8079-4f58-9b54-df434e56ec33/medium/centrum-adults-50-complete-multivitamin.png https://www.technologytimesnewjersey.com/article/910233653-centrum-lance-sa-multivitamine-compl-te-adultes-50-nouvellement-reformul-e-avec-des-bienfaits-cognitifs-d-montr-s-cliniquement Technology Times New Jersey en PressRelease 2026-05-04T11:00:00+00:00 Centrum lance sa multivitamine complète Adultes 50+ nouvellement reformulée avec des bienfaits cognitifs démontrés cliniquement https://ml.globenewswire.com/media/abbbfaf3-e52b-413c-9ded-52f74cf50911/medium/centrum-multivitamine-complete-pour-adultes-50.png https://www.technologytimesnewjersey.com/article/910233661-genyro-announces-new-paper-demonstrating-how-sidewinder-technology-democratizes-dna-construction-at-scale-and-facilitates-ai-driven-protein-design Technology Times New Jersey en PressRelease 2026-05-04T11:00:00+00:00 Genyro Announces New Paper Demonstrating How Sidewinder Technology Democratizes DNA Construction at Scale and Facilitates AI-Driven Protein Design https://ml.globenewswire.com/media/346f123b-cc5d-4de0-a31f-9c4f1315c070/medium/genyro-co-founders.jpg https://www.technologytimesnewjersey.com/article/910233678-seer-announces-appointment-of-anthony-bazarko-as-chief-commercial-officer Technology Times New Jersey en PressRelease 2026-05-04T11:00:00+00:00 Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer https://ml.globenewswire.com/media/ecdddbc3-8a58-4cba-a4a1-33971e79339a/medium/anthony-bazarko.jpg https://www.technologytimesnewjersey.com/article/910233683-istios-health-partners-with-care-id-to-expand-national-infectious-disease-clinical-research-network Technology Times New Jersey en PressRelease 2026-05-04T11:00:00+00:00 Istios Health Partners with CARE-ID to Expand National Infectious Disease Clinical Research Network https://ml.globenewswire.com/media/MTI0OGVmYTMtNmZkNC00ODA4LWJlNzUtNTYxODJlODcxNDBmLTEzMTYxMjEtMjAyNi0wNS0wNC1lbg==/tiny/Istios-Health.png https://www.technologytimesnewjersey.com/article/910233687-adma-biologics-announces-fda-approval-to-expand-the-label-for-asceniv-to-include-pediatric-immune-compromised-patients-two-years-of-age-and-older Technology Times New Jersey en PressRelease 2026-05-04T11:00:00+00:00 ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg https://www.technologytimesnewjersey.com/article/910233694-meet-sprysite-the-website-builder-and-marketing-platform-redefining-small-business-websites Technology Times New Jersey en PressRelease 2026-05-04T11:00:00+00:00 Meet SprySite: The Website Builder and Marketing Platform Redefining Small Business Websites https://pressranger.s3.us-west-1.amazonaws.com/3244560/sprypro.png https://www.technologytimesnewjersey.com/article/910233575-descartes-sets-date-to-announce-first-quarter-fiscal-2027-financial-results Technology Times New Jersey en PressRelease 2026-05-04T10:45:00+00:00 Descartes Sets Date to Announce First Quarter Fiscal 2027 Financial Results https://ml.globenewswire.com/media/2fab20c0-6dcb-4891-840a-37d0d482f33a/small/descartes-systems-group-logo-jpg.jpg https://www.technologytimesnewjersey.com/article/910233704-cabaletta-bio-announces-pricing-of-150-million-underwritten-offering Technology Times New Jersey en PressRelease 2026-05-04T10:35:54+00:00 Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering https://ml.globenewswire.com/media/44175396-6bbb-435f-b037-54a4052160d4/small/cabaletta-bio-registered-logo-png.png https://www.technologytimesnewjersey.com/article/910224348-aura-biosciences-announces-proposed-public-offering-of-common-stock-and-pre-funded-warrants Technology Times New Jersey en PressRelease 2026-05-04T10:03:00+00:00 Aura Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg https://www.technologytimesnewjersey.com/article/910224335-aura-biosciences-announces-ceo-transition-as-company-advances-phase-3-compass-trial-toward-enrollment-completion Technology Times New Jersey en PressRelease 2026-05-04T10:01:00+00:00 Aura Biosciences Announces CEO Transition as Company Advances Phase 3 CoMpass Trial Toward Enrollment Completion https://ml.globenewswire.com/media/92103c30-8e5a-4502-9ec4-0f3b3bd9bb83/small/aura-biosciences-1c-orange-large-jpg.jpg https://www.technologytimesnewjersey.com/article/910224345-scilex-holding-company-announces-its-board-of-directors-approved-may-26-2026-as-the-payment-date-of-the-previously-announced-dividend-of-dream-bowl Technology Times New Jersey en PressRelease 2026-05-04T10:00:00+00:00 Scilex Holding Company Announces Its Board of Directors Approved May 26, 2026 as the Payment Date of the Previously Announced Dividend of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the… https://ml.globenewswire.com/media/e2f985bf-0880-4d05-8838-90a69c888cf9/small/logo-jpg.jpg https://www.technologytimesnewjersey.com/article/910216010-what-is-the-best-internet-solution-for-business-travel-why-holafly-for-business-is-becoming-the-preferred-choice-for-global-companies Technology Times New Jersey en PressRelease 2026-05-04T08:54:07+00:00 What is the best internet solution for business travel? Why Holafly for Business is becoming the preferred choice for global companies https://ml-eu.globenewswire.com/media/ff9372ad-41f6-4acc-8266-5578d80cc425/medium/why-holafly-for-business-is-becoming-the-preferred-choice-fo.jpg https://www.technologytimesnewjersey.com/article/910206820-virtune-ab-publ-virtune-hat-die-monatliche-neugewichtung-f-r-april-2026-des-virtune-crypto-altcoin-index-etps-durchgef-hrt Technology Times New Jersey en PressRelease 2026-05-04T08:06:34+00:00 Virtune AB (Publ) („Virtune“) hat die monatliche Neugewichtung für April 2026 des Virtune Crypto Altcoin Index ETPs durchgeführt https://ml-eu.globenewswire.com/media/da0bec69-79eb-4618-87fd-d96aa395aaed/small/ https://www.technologytimesnewjersey.com/article/910206825-virtune-ab-publ-virtune-has-completed-the-monthly-rebalancing-for-april-2026-of-its-virtune-crypto-altcoin-index-etp Technology Times New Jersey en PressRelease 2026-05-04T08:06:34+00:00 Virtune AB (Publ) ("Virtune") has completed the monthly rebalancing for April 2026 of its Virtune Crypto Altcoin Index ETP https://ml-eu.globenewswire.com/media/da0bec69-79eb-4618-87fd-d96aa395aaed/small/logo-png.png https://www.technologytimesnewjersey.com/article/910206829-virtune-ab-publ-virtune-har-genomf-rt-den-m-natliga-rebalanseringen-f-r-april-2026-av-virtune-crypto-altcoin-index-etp Technology Times New Jersey en PressRelease 2026-05-04T08:06:34+00:00 Virtune AB (Publ) ("Virtune") har genomfört den månatliga rebalanseringen för april 2026 av Virtune Crypto Altcoin Index ETP https://ml-eu.globenewswire.com/media/da0bec69-79eb-4618-87fd-d96aa395aaed/small/ https://www.technologytimesnewjersey.com/article/910188220-proper-hills-launches-ultra-slim-alloy-magnetic-power-bank-for-design-conscious-consumers Technology Times New Jersey en PressRelease 2026-05-04T05:30:58+00:00 Proper Hills Launches Ultra-Slim Alloy Magnetic Power Bank for Design-Conscious Consumers https://ml.globenewswire.com/media/382df764-328b-4049-8389-ac0950f52367/medium/proper-hills-just-made-a-power-bank-thinner-than-a-pencil-th.png https://www.technologytimesnewjersey.com/article/910177238-unbounded-vision-dreame-window-cleaning-robot-debuts-in-north-america-redefining-vertical-cleaning-with-precision-technology Technology Times New Jersey en PressRelease 2026-05-04T04:17:56+00:00 Unbounded Vision: Dreame Window Cleaning Robot Debuts in North America, Redefining Vertical Cleaning with Precision Technology https://ml.globenewswire.com/Resource/Download/d9c436d7-c9c5-46ff-8495-5a11d321f6a3/3-5.png https://www.technologytimesnewjersey.com/article/910162333-lakefusion-raises-7-5m-seed-financing-to-redefine-master-data-management-mdm-natively-on-databricks Technology Times New Jersey en PressRelease 2026-05-04T02:02:10+00:00 LakeFusion Raises $7.5M Seed Financing to Redefine Master Data Management (MDM) Natively on Databricks https://ml.globenewswire.com/media/78680f0e-2aae-4cb5-8bf0-8e3d8bb6b896/medium/lakefusion-raises-7-5m-seed-financing-to-redefine-master-dat.png https://www.technologytimesnewjersey.com/article/910150844-novelty-nobility-taps-agc-biologics-to-further-develop-bispecific-drug-candidate Technology Times New Jersey en PressRelease 2026-05-04T00:00:00+00:00 Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate https://ml.globenewswire.com/media/cecf4f80-22df-4bbf-b0a7-f50b9acf9495/medium/agc-biologics-and-novelty-nobility-representatives-meet.png https://www.technologytimesnewjersey.com/article/910150881-agc Technology Times New Jersey en PressRelease 2026-05-04T00:00:00+00:00 ノベルティ・ノビリティ、AGCバイオロジクスと提携し、二重特異性抗体候補薬の開発を推進 https://ml.globenewswire.com/media/NWUzMzQxMTYtZjcyYS00YjQ4LWE2ODYtY2ZiNWE0YTlmM2MzLTEzMTU5MjMtMjAyNi0wNS0wNC1qYQ==/tiny/AGC-Biologics-Inc-.png https://www.technologytimesnewjersey.com/article/910150885-novelty-nobility-agc-biologics Technology Times New Jersey en PressRelease 2026-05-04T00:00:00+00:00 노벨티 노빌리티 (Novelty Nobility), 이중특이성 항체 개발 위해 AGC Biologics와 협력 확대 https://ml.globenewswire.com/media/NWUzMzQxMTYtZjcyYS00YjQ4LWE2ODYtY2ZiNWE0YTlmM2MzLTEzMTU5MjMtMjAyNi0wNS0wNC1rbw==/tiny/AGC-Biologics-Inc-.png https://www.technologytimesnewjersey.com/article/910145359-crypto-news-today-alphapepe-presale-ai-dex-hits-final-testing-whilst-bitcoin-price-prediction-points-to-120-000 Technology Times New Jersey en PressRelease 2026-05-03T23:30:00+00:00 Crypto News Today: AlphaPepe Presale AI DEX Hits Final Testing Whilst Bitcoin Price Prediction Points to $120,000 https://ml.globenewswire.com/media/2c8b0156-2a64-4138-b75f-f7aaa8bdfd49/medium/alphapepe.jpg https://www.technologytimesnewjersey.com/article/910130237-neuro-salt-under-investigation-full-pink-salt-trick-consumer-report-reveals-shocking-hidden-risks Technology Times New Jersey en PressRelease 2026-05-03T20:52:12+00:00 Neuro Salt Under Investigation: Full "Pink Salt Trick" Consumer Report Reveals Shocking Hidden Risks https://ml.globenewswire.com/media/5b7201ce-5f4e-4a97-9fe8-95a77e66b2b7/medium/neuro-salt.png https://www.technologytimesnewjersey.com/article/910111834-luma-glasses-unveiled-does-lumaglasses-smart-ai-glasses-really-works-read-luma-glasses-consumer-report Technology Times New Jersey en PressRelease 2026-05-03T18:16:40+00:00 Luma Glasses Unveiled: Does LumaGlasses Smart AI Glasses Really Works? Read Luma Glasses Consumer Report! https://ml.globenewswire.com/media/c2a2f020-e4e2-491b-aa89-89d3efaa0309/medium/luma-glasses.png https://www.technologytimesnewjersey.com/article/910074985-russian-oil-asset-fund-launches-public-website-and-solana-token-information-hub-for-roaf Technology Times New Jersey en PressRelease 2026-05-03T13:00:00+00:00 Russian Oil Asset Fund Launches Public Website and Solana Token Information Hub for $ROAF https://ml.globenewswire.com/media/a1ac6677-6dcc-4559-8941-b2ce8d5537ad/small/555-jpg.jpg https://www.technologytimesnewjersey.com/article/910068316-bsstrategy-introduces-ai-powered-trading-workspace-for-strategy-development-and-portfolio-management Technology Times New Jersey en PressRelease 2026-05-03T12:00:00+00:00 BsStrategy Introduces AI-Powered Trading Workspace for Strategy Development and Portfolio Management https://ml.globenewswire.com/media/29228b48-2078-4e24-8423-55e6f010abde/medium/bsstrategy-logo.png https://www.technologytimesnewjersey.com/article/910026702-stellarspace-stellt-bei-einer-auftaktveranstaltung-im-silicon-valley-produkte-der-neuen-generation-f-r-die-industrielle-automatisierung-vor Technology Times New Jersey en PressRelease 2026-05-03T05:09:19+00:00 StellarSpace stellt bei einer Auftaktveranstaltung im Silicon Valley Produkte der neuen Generation für die industrielle Automatisierung vor https://ml.globenewswire.com/Resource/Download/30183e94-1d9e-4c76-980e-bb4a59888b14/image2.png https://www.technologytimesnewjersey.com/article/910026705-stellarspace-presenta-i-prodotti-di-automazione-industriale-di-nuova-generazione-all-evento-di-lancio-nella-silicon-valley Technology Times New Jersey en PressRelease 2026-05-03T05:09:19+00:00 StellarSpace presenta i prodotti di automazione industriale di nuova generazione all’evento di lancio nella Silicon Valley https://ml.globenewswire.com/Resource/Download/670deeb7-29d8-4511-a37d-3bf43c3f7439/image2.png https://www.technologytimesnewjersey.com/article/910026708-stellarspace-silikon-vadisi-lansman-etkinli-inde-yeni-nesil-end-striyel-otomasyon-r-nlerini-lk-defa-tan-tt Technology Times New Jersey en PressRelease 2026-05-03T05:09:19+00:00 StellarSpace, Silikon Vadisi Lansman Etkinliğinde Yeni Nesil Endüstriyel Otomasyon Ürünlerini İlk Defa Tanıttı https://ml.globenewswire.com/Resource/Download/fcc7913a-5f01-4e26-8286-5362ebe4e600/image2.png https://www.technologytimesnewjersey.com/article/909991121-crypto-news-today-alphapepe-presale-nears-1-1m-raised-whilst-cardano-price-prediction-targets-5-00 Technology Times New Jersey en PressRelease 2026-05-02T23:15:00+00:00 Crypto News Today: AlphaPepe Presale Nears $1.1M Raised Whilst Cardano Price Prediction Targets $5.00 https://ml.globenewswire.com/media/34d416a1-fa87-4a5c-abbc-3481d45ef3d6/medium/alphapepe.jpg https://www.technologytimesnewjersey.com/article/909969645-steel-power-unveiled-is-steelpower-male-enhancement-formula-legit-read-steel-power-supplement-report Technology Times New Jersey en PressRelease 2026-05-02T20:17:43+00:00 Steel Power Unveiled: Is SteelPower Male Enhancement Formula Legit? Read Steel Power Supplement Report! https://ml.globenewswire.com/media/a72b8f73-ebbf-4e16-8153-45cfb16c860a/medium/steel-power.png https://www.technologytimesnewjersey.com/article/909966556-halogrow-analyzed-why-is-halo-grow-hair-growth-spray-trending-in-the-united-states Technology Times New Jersey en PressRelease 2026-05-02T19:54:23+00:00 HaloGrow Analyzed: Why Is Halo Grow Hair Growth Spray Trending In The United States? https://ml.globenewswire.com/media/619137e3-80dd-4a54-98b2-0f0f53b14f89/medium/halogrow.png https://www.technologytimesnewjersey.com/article/909960753-silicon-valley-101-and-power-hf-host-ai-infrastructure-forum-spotlighting-power-as-the-next-battleground Technology Times New Jersey en PressRelease 2026-05-02T19:23:00+00:00 Silicon Valley 101 and Power HF Host AI Infrastructure Forum, Spotlighting Power as the Next Battleground https://ml.globenewswire.com/Resource/Download/f3474421-ae5e-497f-900d-632ec537be95/2-5.png https://www.technologytimesnewjersey.com/article/909957746-syngas-obd-fuel-saver-2026-claims-examined-pricing-verified-what-consumers-should-confirm-before-buying Technology Times New Jersey en PressRelease 2026-05-02T19:09:50+00:00 SynGas OBD Fuel Saver 2026: Claims Examined, Pricing Verified & What Consumers Should Confirm Before Buying https://ml.globenewswire.com/media/0ad3879f-8349-4223-b5af-47376ae2701b/medium/syngas.png